Noninvasive Innovation JelikaLite is developing Cognilum, a noninvasive wearable device and AI-powered platform aimed at pediatric neurological health, presenting a sales opportunity for medical device partnerships, clinics, and payors seeking home-based autism therapies and cost-effective interventions.

Cost Reduction Narrative Cognilum aims to reduce lifelong education and residential care costs for autism, a value proposition that can resonate with government programs, insurers, and school systems seeking long-term savings and outcomes-driven funding.

Early Market Momentum Public mentions since 2021 of Cognilum development and early access waitlists indicate traction and interest, suggesting potential for pilot programs, clinical collaborations, and early adopter partnerships to validate efficacy.

Strategic Partnerships Past collaboration with Brain Scientific signals openness to ecosystem partnerships; this can be leveraged to co-develop trials, expand distribution, and access neurology-focused networks and channels.

Small Team, Global Potential With a lean 2-10 employee base and a scalable tech stack (AI platform, wearable device, cloud services), JelikaLite presents opportunities for channel partners, OEM collaborations, and multi-market pilots to accelerate growth while maintaining agility.